Search Medical Condition
Please enter condition
Please choose location from dropdown

Alesund, Norway Clinical Trials

A listing of Alesund, Norway clinical trials actively recruiting patients volunteers.

RESULTS

Found (22) clinical trials

A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Myeloma.

This registry is a prospective, multi-center, observational study and will collect safety data on multiple myeloma adult patients who have received at least two prior therapies and take IMNOVID (pomalidomide) as part of standard care. The registry will remain open until 500 patients will have received at least 3 cycles ...

Phase N/A

0.0 miles

Learn More »

Molecular Markers in Treatment in Endometrial Cancer

This is a prospective multicenter study to investigate the predictive value of molecular markers in endometrial cancer for lymph node metastasis, prognosis and treatment. For the previously studied tumor markers p53, p16, ER, PR and HER2neu, we want to investigate the expression in curettage material in relation to lymph node ...

Phase N/A

0.0 miles

Learn More »

Predicting Relapse of Ulcerative Colitis With Gastrointestinal Ultrasound

INTRODUCTION AND RATIONALE 1.1 Introduction This protocol describes PRELAPSE, an explorative, prospective, longitudinal observational study of diagnostic accuracy comparing trans-abdominal gastrointestinal ultrasound (GIUS) with ileocolonoscopy for the assessment of disease activity in patients with ulcerative colitis (UC) and with regards relapse as an outcome. 1.2 Background Ulcerative colitis is an ...

Phase N/A

0.0 miles

Learn More »

Marine Protein Hydrolysate as Dietary Supplement in Elderly Part II

The potential use of marine protein hydrolysates (MPH) as a supplement with similar or better health benefits than a regular white fish meal, can be regarded both cost-effective, environmental friendly and sustainable. The aim of this study is to investigate the potential effect of increasing/different doses of MPH supplement on ...

Phase N/A

0.0 miles

Learn More »

The Norwegian Nucleoside Analogue Stop Study

Globally, an estimated 257 million individuals have chronic hepatitis B-virus infection (CHB). In the absence of treatment 15-40% of these will progress to liver cirrhosis and/or hepatocellular carcinoma. Oral antiviral treatment suppresses the virus and improves prognosis, but less than 0.5% per year achieve a "functional cure" (i.e. HBsAg loss). ...

Phase

0.0 miles

Learn More »

The CalproSmartNOR Study - a New Clinical Tool for Monitoring Patients With Inflammatory Bowel Disease

There has been a shift in the therapeutic approach for inflammatory bowel disease (IBD) from symptom-tailored towards inflammation-targeted treatments. Mucosal healing, although not well-defined in past literature, is an objective marker of improvement as well as of favorable prognosis, not only in trials but also in routine clinical practice. However, ...

Phase N/A

0.0 miles

Learn More »

PALLiON - PALLiative Care In ONcology

Patients with incurable disease who receive intensive treatment at EoL have worse quality of life (QoL) compared with those receiving symptomatic treatment. Also, a PC approach at an early stage in patients with unfavorable prognosis may improve patients' QoL and symptom control, may lead to prolonged survival and give patients ...

Phase N/A

0.0 miles

Learn More »

Acute and Long-term Cardiovascular Toxicity After Modern Radiotherapy for Breast Cancer

The study is an observational study. In 2007-2012 conventional RT was part of the common treatment regime for breast cancer, but has recently been replaced by laser assisted breath controlled RT. Thus, two cohorts of breast cancer patients treated with different modes of RT will be followed for the development ...

Phase N/A

0.0 miles

Learn More »

The Norwegian Drug Monitoring Study

Infliximab and other TNF-inhibitors have revolutionised the treatment of several immunological inflammatory diseases. Still, more than half of the patients either do not respond sufficiently to infliximab therapy or loose efficacy over time. The large individual variation in the serum drug concentrations on standard doses and the development of anti-drug ...

Phase N/A

0.0 miles

Learn More »

Study of the Efficacy Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic Moderate-to-severe Lower Limb Post-amputation Stump Pain

Primary: To compare the analgesic effect over 12 weeks of topical 2PX in stump pain. Secondary: To prospectively measure other efficacy and safety variables of topical 2PX in stump pain. Exploratory analyses will be performed to measure efficacy and safety variables of topical 2PX in phantom pain

Phase

0.0 miles

Learn More »